A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT05215067 · COMPLETED

Trial details

NCT number: NCT05215067
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer

Start date: 2022-05-13
Primary completion: 2026-01-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.